Balyasny Asset Management
HLTH

Balyasny Asset Management’s Cue Health Inc. Common Stock HLTH Stock Holding History

Balyasny Asset Management’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,893
Closed -$10.6K – 3002
2023
Q3 		$10.6K Sell
23,893
-95,896
-80% -$43.7K ﹤0.01% 2184
2023
Q2 		$44.2K Buy
+119,789
New +$102K ﹤0.01% 2138
2023
Q1 		– Sell
-193,749
Closed -$401K – 3277
2022
Q4 		$401K Sell
193,749
-21,525
-10% -$68K ﹤0.01% 1910
2022
Q3 		$648K Buy
+215,274
New +$763K ﹤0.01% 1961

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's HLTH Position: Q4 2023 in Review

Balyasny Asset Management sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2023, closing a stake of 23,893 shares — an estimated $10.6K sold.

Balyasny Asset Management first reported a position in HLTH in Q3 2022 and held it in 4 quarters. The position peaked at $648K in Q3 2022. 63 funds tracked by Wall St. Rank hold HLTH as of Q4 2023.

  • Balyasny Asset Management reported no remaining Cue Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 23,893 Cue Health Inc. Common Stock shares in Q4 2023, an estimated $10.6K.
  • Balyasny Asset Management first reported a position in Cue Health Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Balyasny Asset Management's Cue Health Inc. Common Stock position peaked at $648K in Q3 2022.
  • 63 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2023.

Based on Balyasny Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.